中文 | English
Return
Total: 7 , 1/1
Show Home Prev Next End page: GO
Author:(TAN WENFU)

1.Establishment of a trauma center improves therapeutic efficacy for patients with severe multiple injuries

Wenfu TAN ; Min HE ; Yong FU ; Zhengmao LI ; Jianchun TAO ; Bin PENG

Chinese Journal of Orthopaedic Trauma 2021;23(2):138-142

2.3D printing used to assist treatment of pilon fracture combined with ipsilateral tibial shaft fracture

Min HE ; Wenfu TAN ; Ningtai TAN ; Bin CHEN ; Jianchun TAO ; Zhengmao LI

Chinese Journal of Orthopaedic Trauma 2019;21(7):604-608

3.Lung cancer risk associated with genetic polymorphism in myeloperoxidase (-463 G/A) in a Chinese population.

Wenfu LU ; Jun QI ; Deyin XING ; Wen TAN ; Xiaoping MIAO ; Wei SU ; Min WU ; Dongxin LIN

Chinese Journal of Oncology 2002;24(3):250-253

4.Value of tumor-associated CD66b-positive neutrophils for the prediction of the recur-rence of stage Ib and IIa cervical cancer

YAN BIN ; CHEN HUIJUN ; GAO HAN ; TAN WENFU ; CAI HONGNING ; ZHOU ZHIGANG ; DAI XUAN ; ZHU FAXIA ; XIONG YUJING

Chinese Journal of Clinical Oncology 2017;44(21):1071-1075

5.Effects of calcium sulfate on proliferation of osteoblast-like MG-63 cells and osteoprotegerin/receptor activator of NF-κB ligand/receptor activator of NF-κB system

Zhengmao LI ; Bin CHEN ; Zhi CUI ; Wenfu TAN ; Min HE

Chinese Journal of Orthopaedic Trauma 2021;23(8):707-710

6.A novel retrograde tibial nail for treatment of distal tibial fracture: preliminary results

Min HE ; Zhengmao LI ; Wenfu TAN ; Yong FU ; Qinglan WEI ; Bin PENG

Chinese Journal of Orthopaedic Trauma 2022;24(4):334-338

7.Development of hedgehog pathway inhibitors by epigenetically targeting GLI through BET bromodomain for the treatment of medulloblastoma.

Xiaohua LIU ; Yu ZHANG ; Yalei LI ; Juan WANG ; Huaqian DING ; Wenjing HUANG ; Chunyong DING ; Hongchun LIU ; Wenfu TAN ; Ao ZHANG

Acta Pharmaceutica Sinica B 2021;11(2):488-504

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 7 , 1/1 Show Home Prev Next End page: GO